Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Single-Domain Antibody
100%
Immunomodulation
100%
Antigen Specificity
100%
Immune Response
100%
Macrophage
83%
Immune Checkpoint Blockade
83%
Immunocompetent Cell
83%
CD20
83%
Programmed Death-Ligand 1
50%
Programmed Death 1 Ligand 1
50%
Splenocyte
41%
Granulocyte Macrophage Colony-Stimulating Factor
41%
Monocyte Chemotactic Protein 1
41%
Cytokine
41%
Chemokine
41%
Interferon
41%
Dendritic Cell
41%
Blood Level
41%
Immunosuppressive Drug
41%
Serum (Blood)
41%
T Cell
41%
Programmed Death 1 Receptor
16%
Medicine and Dentistry
Nanobody
100%
Tumor Microenvironment
100%
Immune Response
100%
Immunomodulation
100%
Actinium 225
100%
Targeted Radionuclide Therapy
100%
Antigen Specificity
100%
Targeted Therapy
50%
Adverse Event
17%
Immunocompetent Cell
17%
Therapy Effect
17%
Macrophage
17%
CD20
17%
Immune Checkpoint Blockade
17%
Programmed Death 1 Ligand 1
12%
Programmed Death-Ligand 1
9%
Tumor
8%
Neoplasm
8%
Flow Cytometry
8%
Radioisotope
8%
Kidney Injury
8%
Monocyte Chemotactic Protein 1
8%
Tumor Progression
8%
T-Cell Response
8%
Interferon
8%
Chemokine
8%
Ovalbumin
8%
Immunosuppressive Drug
8%
Melanoma B16
8%
Dendritic Cell
8%
Effective Treatment
8%
Cytokine
8%
Micrometastasis
8%
Granulocyte Macrophage Colony Stimulating Factor
8%
Pharmacology, Toxicology and Pharmaceutical Science
Nanobody
100%
Tumor Microenvironment
100%
Immunomodulation
100%
Actinium 225
100%
Radioisotope
100%
Antigen
100%
Adverse Event
16%
Therapeutic Effect
16%
Programmed Death 1 Ligand 1
11%
Neoplasm
8%
Flow Cytometry
8%
Interferon
8%
Monocyte Chemotactic Protein 1
8%
Granulocyte Macrophage Colony Stimulating Factor
8%
Tumor Growth
8%
Cytokine
8%
Melanoma B16
8%
Immunosuppressive Agent
8%
Kidney Injury
8%
Chemokine
8%
Micrometastasis
8%
Ovalbumin
8%